scholarly journals Chronic kidney disease and incident apparent treatment-resistant hypertension among blacks: Data from the Jackson Heart Study

2017 ◽  
Vol 19 (11) ◽  
pp. 1117-1124 ◽  
Author(s):  
Rikki M. Tanner ◽  
Daichi Shimbo ◽  
Marguerite R. Irvin ◽  
Tanya M. Spruill ◽  
Samantha G. Bromfield ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Resistant Hypertension ◽  
Jackson Heart Study ◽  
Treatment Resistant ◽  
Heart Study

scholarly journals Relation of multi-marker panel to incident chronic kidney disease and rapid kidney function decline in African Americans: the Jackson Heart Study

2018 ◽  
Vol 19 (1) ◽  
Author(s):  
Stanford E. Mwasongwe ◽  
Bessie Young ◽  
Aurelian Bidulescu ◽  
Mario Sims ◽  
Adolfo Correa ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
African Americans ◽  
Kidney Disease ◽  
Kidney Function ◽  
Jackson Heart Study ◽  
Marker Panel ◽  
Heart Study ◽  
Incident Chronic Kidney Disease ◽  
Kidney Function Decline

Abstract P099: The Relation of Kidney Disease to Measures of Digital Arterial Tonometry in the Jackson Heart Study

Circulation ◽  
2012 ◽  
Vol 125 (suppl_10) ◽  
Author(s):  
Eric McClendon ◽  
Solomon Musani ◽  
Sushante Khaire ◽  
Herman Taylor ◽  
Ervin Fox
Keyword(s):  
Chronic Kidney Disease ◽  
African Americans ◽  
Endothelial Dysfunction ◽  
Kidney Disease ◽  
Least Square ◽  
Jackson Heart Study ◽  
Pulse Wave Amplitude ◽  
Arterial Tonometry ◽  
Heart Study ◽  
Age And Sex

Background: The presence of chronic kidney disease is greater in African Americans than in non-Hispanic whites. Though there is data to show a relation between endothelial dysfunction and end-stage kidney disease, the relation to mild and moderate chronic kidney disease (particularly in African Americans) is unclear. Methods and Results: Digital arterial tonometry was performed during Exam 2 and 3 of the Jackson Heart Study using the endoPAT2000. Data from digital arterial tonometry included baseline pulse wave amplitude (BPA) as a measure of endothelial tone and reactive hyperemic index (F-RHI) as a measure of endothelial function. For this study, the estimated glomerular filtration rate (eGFR) was calculated using the MDRD equation. Those participants with eGFR < 60 ml/min/1.73m2 were defined as having CKD. Participants with eGFR < 15 ml/min/1.73m2 were excluded from the analysis. Microalbuminuria in this study was defined as a urinary albumin:creatinine ratio ≥ 17mg/g in men and ≥ 25 mg/g in women. We compared the differences in least square means adjusted for age and sex, and adjusted for multiple traditional clinical covariates using a generalized linear model. Results: There were 834 participants in the study population (mean age 58.5 years, 61% women); 87 (10.4%) participants with CKD and 108 (13.0%) with microalbuminuria. In age and sex adjusted samples, we found that both BPA and F-RHI were significantly associated with CKD in the pooled samples. However in multivariable adjusted analysis the relation was no longer significant in either the pooled or sex-specific samples. In the multivariable adusted analysis,BPA was significantly (P=0.036) associated with microalbuminuria in men and F-RHI was weakly significantly (P=0.08) associated with microalbuminuria in women. Conclusion: We found that endothelial dysfunction as measured by digital arterial tonometry is not significantly associated with chronic kidney disease. There is an association of endothelial tone in men and endothelial dysfunction in women with microalbuminuria.

scholarly journals FP092CLINICAL CHARACTERISTICS OF APPARENT TREATMENT-RESISTANT HYPERTENSION IN CHRONIC KIDNEY DISEASE PATIENTS EVALUATED BY 24 HOUR AMBULATORY BLOOD PRESSURE MONITORING

2015 ◽  
Vol 30 (suppl_3) ◽  
pp. iii97-iii97
Author(s):  
Biljana Gerasimovska Kitanovska ◽  
Stevka Bogdanovska ◽  
Svetlana Pavleska Kuzmanovska ◽  
Vesna Gerasimovska ◽  
Aleksandar Sikole
Keyword(s):  
Blood Pressure ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Ambulatory Blood Pressure Monitoring ◽  
Ambulatory Blood Pressure ◽  
Resistant Hypertension ◽  
Blood Pressure Monitoring ◽  
Treatment Resistant ◽  
Pressure Monitoring

scholarly journals The association of nocturnal hypertension and nondipping blood pressure with treatment-resistant hypertension: The Jackson Heart Study

2018 ◽  
Vol 20 (3) ◽  
pp. 438-446 ◽  
Author(s):  
Marguerite R. Irvin ◽  
John N. Booth ◽  
Mario Sims ◽  
Adam P. Bress ◽  
Marwah Abdalla ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Resistant Hypertension ◽  
Jackson Heart Study ◽  
Treatment Resistant ◽  
Nocturnal Hypertension ◽  
Heart Study

scholarly journals Effect of Arteriovenous Fistula Creation on Systolic and Diastolic Blood Pressure in Patients With Pre-dialysis Advanced Chronic Kidney Disease

2019 ◽  
Vol 32 (9) ◽  
pp. 858-867 ◽  
Author(s):  
Roy O Mathew ◽  
Jerome Fleg ◽  
Janani Rangaswami ◽  
Bo Cai ◽  
Arif Asif ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Arteriovenous Fistula ◽  
Resistant Hypertension ◽  
Repeated Measures ◽  
Treatment Resistant ◽  
Advanced Chronic Kidney Disease ◽  
Stage Renal Disease ◽  
End Stage

AbstractBACKGROUNDCentral arteriovenous fistula (cAVF) has been investigated as a therapeutic measure for treatment-resistant hypertension in patients without advanced chronic kidney disease (CKD). There is considerable experience with the use of AVF for hemodialysis in patients with end-stage renal disease (ESRD). However, there is sparse data on the blood pressure (BP) effects of an AVF among patients with ESRD. We hypothesized that AVF creation would significantly reduce BP compared with patients who did not have an AVF among patients with ESRD before starting hemodialysis.METHODSBPs were compared during the 12 months before hemodialysis initiation in 399 patients with an AVF or AV graft created and 4,696 patients without either.RESULTSAfter propensity score matching 1:2 ratio (AVF to no AVF), repeated measures analysis of variance revealed significant reductions of –1.7 mm Hg systolic and –3.9 mm Hg diastolic BP 12 months in patients after AVF creation; P = 0.025 and P &lt; 0.001, respectively, compared with those with no AVF.CONCLUSIONSThese findings suggest that AVF creation results in modest BP reduction in patients with pre-dialysis ESRD who require AVF for eventual hemodialysis therapy. Preferential diastolic BP reduction suggests that greater work is needed to characterize the ideal patient subset in which to use cAVF for treatment-resistant hypertension in those without advanced CKD.

scholarly journals Optimism is associated with chronic kidney disease and rapid kidney function decline among African Americans in the Jackson Heart Study

2020 ◽  
Vol 139 ◽  
pp. 110267
Author(s):  
LáShauntá M. Glover ◽  
Crystal Butler-Williams ◽  
Loretta Cain-Shields ◽  
Allana T. Forde ◽  
Tanjala S. Purnell ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
African Americans ◽  
Kidney Disease ◽  
Kidney Function ◽  
Jackson Heart Study ◽  
Heart Study ◽  
Kidney Function Decline

scholarly journals Erratum: Psychosocial correlates of apparent treatment-resistant hypertension in the Jackson Heart Study

2017 ◽  
Vol 31 (7) ◽  
pp. 486-486 ◽  
Author(s):  
A J Shallcross ◽  
M Butler ◽  
R M Tanner ◽  
A P Bress ◽  
P Muntner ◽  
...  
Keyword(s):  
Resistant Hypertension ◽  
Jackson Heart Study ◽  
Treatment Resistant ◽  
Psychosocial Correlates ◽  
Heart Study

scholarly journals Goal-Striving Stress Is Associated with Chronic Kidney Disease Among Participants in the Jackson Heart Study

2018 ◽  
Vol 6 (1) ◽  
pp. 64-69 ◽  
Author(s):  
Loretta R. Cain ◽  
LáShauntá Glover ◽  
Bessie Young ◽  
Mario Sims
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Jackson Heart Study ◽  
Goal Striving ◽  
Heart Study

scholarly journals Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease

Hypertension ◽  
2019 ◽  
Vol 73 (4) ◽  
pp. 785-793 ◽  
Author(s):  
Jing Chen ◽  
Joshua D. Bundy ◽  
L. Lee Hamm ◽  
Chi-yuan Hsu ◽  
James Lash ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Resistant Hypertension ◽  
Treatment Resistant
Sign in / Sign up

Export Citation Format

Share Document